Skip to main content

Closed

ONCY: Oncolytics Biotech Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-1221.8%

Financially safe

Stretched

Debt / equity-0.10×

Interest coverage0.0×

Current ratio1.38×

Oncolytics Biotech Inc.

ONCYNASDAQ·USD·Closed

Oncolytics Biotech Inc.

ONCYNASDAQ·USD·Closed

$0.75

+0.04%

$0.75

+$0.00 (0.04%)

52W Range

3thpctl

Volume

0.59×avg

Mkt Cap

75.60MUSD

P/E

-3.1TTM

Div Yield

–ann

52W Range

3thpctl

Volume

0.59×avg

Market Cap

75.60MUSD

P/E Ratio

-3.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings